Clinical Trials Browser

Spinal Cord Neoplasms, Spinal Stenosis, Spondylolisthesis, Spinal Fractures, Intervertebral Disc Degeneration

NCT05296889 2026-03-31

CERISE

Recruiting

200 enrolled

CNS

Spinal Cord Neoplasms, Spinal Fractures, Intervertebral Disc Degeneration

NCT05170815 2026-03-17

ErYs

Recruiting

760 enrolled

CNS

Spinal Cord Neoplasms, Spinal Fractures

NCT06910618 2025-04-04

Valid-METASTRA

Not yet recruiting

300 enrolled

Neoplasms, Spinal Fractures, Fractures, Bone

NCT06627998 2024-10-04

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

Recruiting

82 enrolled

Head & Neck

Osteoporosis, Thyroid Neoplasms, Spinal Fractures

NCT02931279 2023-11-27

PASS OCT® Post-market Clinical Follow-up

Completed

40 enrolled

Intervertebral disc disease, Spinal Neoplasms, Spinal Stenosis, Spondylolisthesis, Spinal Fractures

NCT05995327 2023-08-24

Reasons and Risk Factors for Unplanned Spinal Re-operation

Unknown

70,000 enrolled

Spinal Fractures

NCT01374412 2022-08-04

Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging

Unknown

144 enrolled

Plasma cell

Multiple Myeloma, Osteoporosis, Spinal Fractures

NCT04609150 2020-11-06

Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)

Unknown

100 enrolled

Plasma cell

Multiple Myeloma, Spinal Fractures

Clinical Trials

INFO SPINE

CERISE

ErYs

Valid-METASTRA

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

PASS OCT® Post-market Clinical Follow-up

Reasons and Risk Factors for Unplanned Spinal Re-operation

Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging

Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)